ADC THERAPEUTICS SA's ticker is ADCT and the CUSIP is H0036K147. A total of 42 filers reported holding ADC THERAPEUTICS SA in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,410,000 | -39.4% | 500,000 | 0.0% | 0.06% | -25.9% |
| Q2 2022 | $3,975,000 | -45.9% | 500,000 | 0.0% | 0.08% | -44.4% |
| Q1 2022 | $7,345,000 | -27.3% | 500,000 | 0.0% | 0.15% | -1.9% |
| Q4 2021 | $10,100,000 | -25.6% | 500,000 | 0.0% | 0.16% | -12.4% |
| Q3 2021 | $13,580,000 | +11.5% | 500,000 | 0.0% | 0.18% | +42.4% |
| Q2 2021 | $12,175,000 | -0.2% | 500,000 | 0.0% | 0.12% | +3.3% |
| Q1 2021 | $12,205,000 | -23.7% | 500,000 | 0.0% | 0.12% | -4.7% |
| Q4 2020 | $16,005,000 | -3.0% | 500,000 | 0.0% | 0.13% | +1.6% |
| Q3 2020 | $16,495,000 | -29.5% | 500,000 | 0.0% | 0.12% | -41.6% |
| Q2 2020 | $23,405,000 | – | 500,000 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 5,402,041 | $4,845,631 | 1.54% |
| Sio Capital Management, LLC | 3,294,534 | $2,955,197 | 0.92% |
| Redmile Group, LLC | 14,178,045 | $12,717,706 | 0.60% |
| AlphaCentric Advisors LLC | 1,068,468 | $958,416 | 0.54% |
| Vantage Consulting Group Inc | 850,737 | $763,111 | 0.51% |
| Blue Owl Capital Holdings LP | 733,568 | $654,489 | 0.51% |
| Affinity Asset Advisors, LLC | 1,100,000 | $986,700 | 0.28% |
| Frazier Life Sciences Management, L.P. | 1,647,030 | $1,477,386 | 0.10% |
| Indie Asset Partners, LLC | 92,700 | $83,152 | 0.08% |
| GCM Grosvenor Holdings, LLC | 410,888 | $368,567 | 0.07% |